vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and MATERION Corp (MTRN). Click either name above to swap in a different company.
MATERION Corp is the larger business by last-quarter revenue ($549.8M vs $359.9M, roughly 1.5× AdvanSix Inc.). MATERION Corp runs the higher net margin — 3.5% vs -0.8%, a 4.3% gap on every dollar of revenue. On growth, MATERION Corp posted the faster year-over-year revenue change (30.8% vs 9.4%). Over the past eight quarters, MATERION Corp's revenue compounded faster (13.6% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Materion Corp. is a multinational company specializing in high-performance advanced materials. Among its products are advanced beryllium metals, thin film deposition materials, high-performance alloys and composites, specialty engineered beryllium, engineered metals, technical ceramics, tantalum, niobium, other precious and non-precious metals, inorganic chemicals, and specialty coatings.
ASIX vs MTRN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $549.8M |
| Net Profit | $-2.8M | $19.4M |
| Gross Margin | 7.6% | 14.9% |
| Operating Margin | -0.7% | 5.1% |
| Net Margin | -0.8% | 3.5% |
| Revenue YoY | 9.4% | 30.8% |
| Net Profit YoY | -892.9% | 9.5% |
| EPS (diluted) | $-0.11 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $549.8M | ||
| Q4 25 | $359.9M | $489.8M | ||
| Q3 25 | $374.5M | $444.8M | ||
| Q2 25 | $410.0M | $431.7M | ||
| Q1 25 | $377.8M | $420.3M | ||
| Q4 24 | $329.1M | $436.9M | ||
| Q3 24 | $398.2M | $436.7M | ||
| Q2 24 | $453.5M | $425.9M |
| Q1 26 | — | $19.4M | ||
| Q4 25 | $-2.8M | $6.6M | ||
| Q3 25 | $-2.6M | $25.4M | ||
| Q2 25 | $31.4M | $25.1M | ||
| Q1 25 | $23.3M | $17.7M | ||
| Q4 24 | $352.0K | $-48.9M | ||
| Q3 24 | $22.3M | $22.3M | ||
| Q2 24 | $38.9M | $19.0M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | 7.6% | 13.0% | ||
| Q3 25 | 6.8% | 19.4% | ||
| Q2 25 | 14.3% | 19.1% | ||
| Q1 25 | 14.2% | 18.1% | ||
| Q4 24 | 3.4% | 21.3% | ||
| Q3 24 | 14.4% | 18.5% | ||
| Q2 24 | 17.9% | 19.0% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | -0.7% | 2.2% | ||
| Q3 25 | -0.9% | 7.9% | ||
| Q2 25 | 7.7% | 8.5% | ||
| Q1 25 | 7.7% | 6.5% | ||
| Q4 24 | -3.9% | -8.8% | ||
| Q3 24 | 7.5% | 7.2% | ||
| Q2 24 | 11.5% | 7.5% |
| Q1 26 | — | 3.5% | ||
| Q4 25 | -0.8% | 1.3% | ||
| Q3 25 | -0.7% | 5.7% | ||
| Q2 25 | 7.7% | 5.8% | ||
| Q1 25 | 6.2% | 4.2% | ||
| Q4 24 | 0.1% | -11.2% | ||
| Q3 24 | 5.6% | 5.1% | ||
| Q2 24 | 8.6% | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | $-0.11 | $0.30 | ||
| Q3 25 | $-0.10 | $1.22 | ||
| Q2 25 | $1.15 | $1.21 | ||
| Q1 25 | $0.86 | $0.85 | ||
| Q4 24 | $0.02 | $-2.34 | ||
| Q3 24 | $0.82 | $1.07 | ||
| Q2 24 | $1.43 | $0.91 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $16.2M |
| Total DebtLower is stronger | — | $489.9M |
| Stockholders' EquityBook value | $815.2M | $957.0M |
| Total Assets | $1.7B | $1.9B |
| Debt / EquityLower = less leverage | — | 0.51× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $16.2M | ||
| Q4 25 | $19.8M | $13.7M | ||
| Q3 25 | $23.7M | $16.4M | ||
| Q2 25 | $18.4M | $12.6M | ||
| Q1 25 | $8.3M | $15.6M | ||
| Q4 24 | $19.6M | $16.7M | ||
| Q3 24 | $17.3M | $17.9M | ||
| Q2 24 | $12.1M | $17.1M |
| Q1 26 | — | $489.9M | ||
| Q4 25 | — | $460.6M | ||
| Q3 25 | — | $458.9M | ||
| Q2 25 | — | $427.6M | ||
| Q1 25 | — | $453.0M | ||
| Q4 24 | — | $443.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | $957.0M | ||
| Q4 25 | $815.2M | $943.3M | ||
| Q3 25 | $818.2M | $934.6M | ||
| Q2 25 | $823.7M | $910.6M | ||
| Q1 25 | $794.4M | $887.9M | ||
| Q4 24 | $774.6M | $868.9M | ||
| Q3 24 | $766.4M | $931.9M | ||
| Q2 24 | $746.6M | $907.1M |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $1.7B | $1.8B | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.7B | ||
| Q1 25 | $1.6B | $1.8B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.5B | $1.9B | ||
| Q2 24 | $1.5B | $1.8B |
| Q1 26 | — | 0.51× | ||
| Q4 25 | — | 0.49× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.47× | ||
| Q1 25 | — | 0.51× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | — |
| Free Cash FlowOCF − Capex | $36.1M | — |
| FCF MarginFCF / Revenue | 10.0% | — |
| Capex IntensityCapex / Revenue | 7.7% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $19.5M | ||
| Q3 25 | $26.6M | $18.3M | ||
| Q2 25 | $21.1M | $49.9M | ||
| Q1 25 | $11.4M | $15.5M | ||
| Q4 24 | $64.2M | $76.3M | ||
| Q3 24 | $57.3M | $5.1M | ||
| Q2 24 | $50.2M | $20.3M |
| Q1 26 | — | — | ||
| Q4 25 | $36.1M | — | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | $3.2M | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $26.8M | $-24.3M | ||
| Q2 24 | $16.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | 0.8% | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | 6.7% | -5.6% | ||
| Q2 24 | 3.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | 2.9% | ||
| Q4 24 | 10.4% | — | ||
| Q3 24 | 7.7% | 6.7% | ||
| Q2 24 | 7.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.97× | ||
| Q3 25 | — | 0.72× | ||
| Q2 25 | 0.67× | 1.99× | ||
| Q1 25 | 0.49× | 0.88× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | 0.23× | ||
| Q2 24 | 1.29× | 1.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
MTRN
Segment breakdown not available.
